{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:56:48Z","timestamp":1793044608006,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA253127"],"award-info":[{"award-number":["R35CA253127"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL155178"],"award-info":[{"award-number":["HL155178"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB2028902"],"award-info":[{"award-number":["MCB2028902"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142213"],"award-info":[{"award-number":["R35GM142213"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41588-024-01911-7","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:05:46Z","timestamp":1726779946000},"page":"2213-2227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity"],"prefix":"10.1038","volume":"56","author":[{"given":"Samuel J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9410-8527","authenticated-orcid":false,"given":"Jacob","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bohorquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goichi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyeeta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Bartholdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Sundaravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelbasset A.","family":"Farahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Wheat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendel","family":"Goldfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Boykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy R.","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-9458","authenticated-orcid":false,"given":"Gregory M. K.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-1795","authenticated-orcid":false,"given":"Ulrich","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 172, 650\u2013665 (2018).","journal-title":"Cell"},{"key":"1911_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-cancerbio-030518-055710","volume":"3","author":"JA Perry","year":"2019","unstructured":"Perry, J. A., Seong, B. K. A. & Stegmaier, K. Biology and therapy of dominant fusion oncoproteins involving transcription factor and chromatin regulators in sarcomas. Annu. Rev. Cancer Biol. 3, 299\u2013321 (2019).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"1911_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","volume":"20","author":"MJ Henley","year":"2021","unstructured":"Henley, M. J. & Koehler, A. N. Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules. Nat. Rev. Drug Discov. 20, 669\u2013688 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1911_CR4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.immuni.2018.04.024","volume":"48","author":"H Hosokawa","year":"2018","unstructured":"Hosokawa, H. et al. Transcription Factor PU.1 represses and activates gene expression in early T\u2009cells by redirecting partner transcription factor binding. Immunity 48, 1119\u20131134.e7 (2018).","journal-title":"Immunity"},{"key":"1911_CR5","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V96.8.2641","volume":"96","author":"P Zhang","year":"2000","unstructured":"Zhang, P. et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96, 2641\u20132648 (2000).","journal-title":"Blood"},{"key":"1911_CR6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1101\/gad.13.11.1398","volume":"13","author":"N Rekhtman","year":"1999","unstructured":"Rekhtman, N., Radparvar, F., Evans, T. & Skoultchi, A. I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13, 1398\u20131411 (1999).","journal-title":"Genes Dev."},{"key":"1911_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2019.07.001","volume":"25","author":"MD McKenzie","year":"2019","unstructured":"McKenzie, M. D. et al. Interconversion between tumorigenic and differentiated states in acute myeloid leukemia. Cell Stem Cell 25, 258\u2013272.e9 (2019).","journal-title":"Cell Stem Cell"},{"key":"1911_CR8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/nar\/gkt955","volume":"42","author":"M Munde","year":"2014","unstructured":"Munde, M. et al. Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines. Nucleic Acids Res. 42, 1379\u20131390 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1911_CR9","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1172\/JCI92504","volume":"127","author":"I Antony-Debr\u00e9","year":"2017","unstructured":"Antony-Debr\u00e9, I. et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J. Clin. Invest. 127, 4297\u20134313 (2017).","journal-title":"J. Clin. Invest."},{"key":"1911_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1911_CR11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1101\/gr.231423.117","volume":"28","author":"J Ungerb\u00e4ck","year":"2018","unstructured":"Ungerb\u00e4ck, J. et al. Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by SPI1 (PU.1). Genome Res. 28, 1508\u20131519 (2018).","journal-title":"Genome Res."},{"key":"1911_CR12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.8079170","volume":"265","author":"EW Scott","year":"1994","unstructured":"Scott, E. W., Simon, M. C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573\u20131577 (1994).","journal-title":"Science"},{"key":"1911_CR13","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1093\/nar\/gkw229","volume":"44","author":"DC Stephens","year":"2016","unstructured":"Stephens, D. C. et al. Pharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis. Nucleic Acids Res. 44, 4005\u20134013 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1911_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116861","volume":"68","author":"EN Ogbonna","year":"2022","unstructured":"Ogbonna, E. N. et al. Drug design and DNA structural research inspired by the Neidle laboratory: DNA minor groove binding and transcription factor inhibition by thiophene diamidines. Bioorg. Med. Chem. 68, 116861 (2022).","journal-title":"Bioorg. Med. Chem."},{"key":"1911_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/leu.2015.172","volume":"30","author":"JI Sive","year":"2016","unstructured":"Sive, J. I. et al. Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia. Leukemia 30, 14\u201323 (2016).","journal-title":"Leukemia"},{"key":"1911_CR16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.3936","volume":"21","author":"B Will","year":"2015","unstructured":"Will, B. et al. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nat. Med. 21, 1172\u20131181 (2015).","journal-title":"Nat. Med."},{"key":"1911_CR17","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI30525","volume":"117","author":"U Steidl","year":"2007","unstructured":"Steidl, U. et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J. Clin. Invest. 117, 2611\u20132620 (2007).","journal-title":"J. Clin. Invest."},{"key":"1911_CR18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/ng1898","volume":"38","author":"U Steidl","year":"2006","unstructured":"Steidl, U. et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat. Genet. 38, 1269\u20131277 (2006).","journal-title":"Nat. Genet."},{"key":"1911_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood-2009-03-212225","volume":"115","author":"N Bonadies","year":"2010","unstructured":"Bonadies, N., Pabst, T. & Mueller, B. U. Heterozygous deletion of the PU.1 locus in human AML. Blood 115, 331\u2013334 (2010).","journal-title":"Blood"},{"key":"1911_CR20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/blood.V100.3.998","volume":"100","author":"BU Mueller","year":"2002","unstructured":"Mueller, B. U. et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 100, 998\u20131007 (2002).","journal-title":"Blood"},{"key":"1911_CR21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2019.08.003","volume":"25","author":"AD Viny","year":"2019","unstructured":"Viny, A. D. et al. Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation. Cell Stem Cell 25, 682\u2013696.e8 (2019).","journal-title":"Cell Stem Cell"},{"key":"1911_CR22","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2002-06-1677","volume":"101","author":"M Mizuki","year":"2003","unstructured":"Mizuki, M. et al. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 101, 3164\u20133173 (2003).","journal-title":"Blood"},{"key":"1911_CR23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","volume":"101","author":"RK Vangala","year":"2003","unstructured":"Vangala, R. K. et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood 101, 270\u2013277 (2003).","journal-title":"Blood"},{"key":"1911_CR24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","volume":"6","author":"MWM K\u00fchn","year":"2016","unstructured":"K\u00fchn, M. W. M. et al. Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer Discov. 6, 1166 (2016).","journal-title":"Cancer Discov."},{"key":"1911_CR25","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1172\/JCI97117","volume":"128","author":"X Gu","year":"2018","unstructured":"Gu, X. et al. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates. J. Clin. Invest. 128, 4260\u20134279 (2018).","journal-title":"J. Clin. Invest."},{"key":"1911_CR26","doi-asserted-by":"crossref","first-page":"e20222105","DOI":"10.1084\/jem.20222105","volume":"220","author":"WT Ralvenius","year":"2023","unstructured":"Ralvenius, W. T. et al. A novel molecular class that recruits HDAC\/MECP2 complexes to PU.1 motifs reduces neuroinflammation. J. Exp. Med. 220, e20222105 (2023).","journal-title":"J. Exp. Med."},{"key":"1911_CR27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jmb.2013.02.010","volume":"425","author":"M Munde","year":"2013","unstructured":"Munde, M., Poon, G. M. K. & Wilson, W. D. Probing the electrostatics and pharmacological modulation of sequence-specific binding by the DNA-binding domain of the ETS family transcription factor PU.1: a binding affinity and kinetics investigation. J. Mol. Biol. 425, 1655\u20131669 (2013).","journal-title":"J. Mol. Biol."},{"key":"1911_CR28","doi-asserted-by":"crossref","first-page":"e1001392","DOI":"10.1371\/journal.pgen.1001392","volume":"7","author":"SN Wontakal","year":"2011","unstructured":"Wontakal, S. N. et al. A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1. PLoS Genet. 7, e1001392 (2011).","journal-title":"PLoS Genet."},{"key":"1911_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41467-019-13960-2","volume":"11","author":"J Minderjahn","year":"2020","unstructured":"Minderjahn, J. et al. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nat. Commun. 11, 402 (2020).","journal-title":"Nat. Commun."},{"key":"1911_CR30","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1093\/nar\/gkt355","volume":"41","author":"TH Pham","year":"2013","unstructured":"Pham, T. H. et al. Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. Nucleic Acids Res. 41, 6391\u20136402 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1911_CR31","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1021\/jp804048c","volume":"112","author":"Y Liu","year":"2008","unstructured":"Liu, Y. et al. Heterocyclic diamidine Interactions at AT base pairs in the DNA minor groove: effects of heterocycle differences, DNA AT sequence and length. J. Phys. Chem. B 112, 11809 (2008).","journal-title":"J. Phys. Chem. B"},{"key":"1911_CR32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193\u20131203 (2016).","journal-title":"Nat. Genet."},{"key":"1911_CR33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molcel.2019.04.011","volume":"74","author":"SA Shariati","year":"2019","unstructured":"Shariati, S. A. et al. Reversible disruption of specific transcription factor\u2013DNA interactions using CRISPR\/Cas9. Mol. Cell 74, 622\u2013633.e4 (2019).","journal-title":"Mol. Cell"},{"key":"1911_CR34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1097-2765(02)00703-7","volume":"10","author":"CR Escalante","year":"2002","unstructured":"Escalante, C. R. et al. Crystal structure of PU.1\/IRF-4\/DNA ternary complex. Mol. Cell 10, 1097\u20131105 (2002).","journal-title":"Mol. Cell"},{"key":"1911_CR35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/jir.2005.25.770","volume":"25","author":"Y Kanno","year":"2005","unstructured":"Kanno, Y., Levi, B. Z., Tamura, T. & Ozato, K. Immune cell-specific amplification of interferon signaling by the IRF-4\/8-PU.1 complex. J. Interferon Cytokine Res. 25, 770\u2013779 (2005).","journal-title":"J. Interferon Cytokine Res."},{"key":"1911_CR36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"1911_CR37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"A Konstantinos Tzelepis","year":"2016","unstructured":"Konstantinos Tzelepis, A. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"1911_CR38","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1016\/j.molcel.2021.07.018","volume":"81","author":"Z Cao","year":"2021","unstructured":"Cao, Z. et al. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Mol. Cell 81, 3604 (2021).","journal-title":"Mol. Cell"},{"key":"1911_CR39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2836(03)00362-0","volume":"328","author":"GMK Poon","year":"2003","unstructured":"Poon, G. M. K. & Macgregor, R. B. Base coupling in sequence-specific site recognition by the ETS domain of murine PU.1. J. Mol. Biol. 328, 805\u2013819 (2003).","journal-title":"J. Mol. Biol."},{"key":"1911_CR40","doi-asserted-by":"crossref","first-page":"18297","DOI":"10.1074\/jbc.M112.342345","volume":"287","author":"GMK Poon","year":"2012","unstructured":"Poon, G. M. K. Sequence discrimination by DNA-binding domain of ETS family transcription factor PU.1 is linked to specific hydration of protein\u2013DNA interface. J. Biol. Chem. 287, 18297\u201318307 (2012).","journal-title":"J. Biol. Chem."},{"key":"1911_CR41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2010.02.008","volume":"32","author":"S Ghisletti","year":"2010","unstructured":"Ghisletti, S. et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32, 317\u2013328 (2010).","journal-title":"Immunity"},{"key":"1911_CR42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.molcel.2014.04.006","volume":"54","author":"I Barozzi","year":"2014","unstructured":"Barozzi, I. et al. Co-regulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol. Cell 54, 844 (2014).","journal-title":"Mol. Cell"},{"key":"1911_CR43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4049\/jimmunol.1501944","volume":"197","author":"H Al Sadoun","year":"2016","unstructured":"Al Sadoun, H., Burgess, M., Hentges, K. E. & Mace, K. A. Enforced expression of Hoxa3 inhibits classical and promotes alternative activation of macrophages in vitro and in vivo. J. Immunol. 197, 872\u2013884 (2016).","journal-title":"J. Immunol."},{"key":"1911_CR44","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1128\/MCB.15.10.5830","volume":"15","author":"S Hohaus","year":"1995","unstructured":"Hohaus, S. et al. PU.1 (Spi-1) and C\/EBP\u03b1 regulate expression of the granulocyte\u2013macrophage colony-stimulating factor receptor \u03b1 gene. Mol. Cell. Biol. 15, 5830\u20135845 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"1911_CR45","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1038\/emboj.2009.340","volume":"28","author":"A Bancaud","year":"2009","unstructured":"Bancaud, A. et al. Molecular crowding affects diffusion and binding of nuclear proteins in heterochromatin and reveals the fractal organization of chromatin. EMBO J. 28, 3785\u20133798 (2009).","journal-title":"EMBO J."},{"key":"1911_CR46","volume":"14","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Chemical-induced phase transition and global conformational reorganization of chromatin. Nat. Commun. 14, 5556 (2023).","journal-title":"Nat. Commun."},{"key":"1911_CR47","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-019-10652-9","volume":"10","author":"CC Bell","year":"2019","unstructured":"Bell, C. C. et al. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. Nat. Commun. 10, 2723 (2019).","journal-title":"Nat. Commun."},{"key":"1911_CR48","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1021\/bi200962u","volume":"50","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Targeting a DNA binding motif of the EVI1 protein by a pyrrole\u2013imidazole polyamide. Biochemistry 50, 10431\u201310441 (2011).","journal-title":"Biochemistry"},{"key":"1911_CR49","doi-asserted-by":"crossref","first-page":"24246","DOI":"10.1074\/jbc.M000820200","volume":"275","author":"SY Chiang","year":"2000","unstructured":"Chiang, S. Y. et al. Targeting the Ets binding site of the HER2\/neu promoter with pyrrole\u2013imidazole polyamides. J. Biol. Chem. 275, 24246\u201324254 (2000).","journal-title":"J. Biol. Chem."},{"key":"1911_CR50","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1093\/nar\/gkn208","volume":"36","author":"P Peixoto","year":"2008","unstructured":"Peixoto, P. et al. Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication. Nucleic Acids Res. 36, 3341\u20133353 (2008).","journal-title":"Nucleic Acids Res."},{"key":"1911_CR51","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2006.11.087","volume":"366","author":"LA Cirillo","year":"2007","unstructured":"Cirillo, L. A. & Zaret, K. S. Specific Interactions of the wing domains of FOXA1 transcription factor with DNA. J. Mol. Biol. 366, 720 (2007).","journal-title":"J. Mol. Biol."},{"key":"1911_CR52","first-page":"E6600","volume":"113","author":"X Fu","year":"2016","unstructured":"Fu, X. et al. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. Proc. Natl Acad. Sci. USA 113, E6600\u2013E6609 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1911_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fonc.2017.00241","volume":"7","author":"R Lu","year":"2017","unstructured":"Lu, R. & Wang, G. G. Pharmacologic targeting of chromatin modulators as therapeutics of acute myeloid leukemia. Front. Oncol. 7, 241 (2017).","journal-title":"Front. Oncol."},{"key":"1911_CR54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2014-06-581082","volume":"125","author":"B Xu","year":"2015","unstructured":"Xu, B. et al. Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia. Blood 125, 346\u2013357 (2015).","journal-title":"Blood"},{"key":"1911_CR55","first-page":"1043","volume":"164","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Liu, M., Yao, Y., Yu, B. & Liu, H. Targeting LSD1 for acute myeloid leukemia (AML) treatment. Pharmacol. Res. 164, 1043\u20136618 (2021).","journal-title":"Pharmacol. Res."},{"key":"1911_CR56","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1021\/ja211628j","volume":"134","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. Designed compounds for recognition of 10 base pairs of DNA with two at binding sites. J. Am. Chem. Soc. 134, 5290\u20135299 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"1911_CR57","doi-asserted-by":"crossref","first-page":"19386","DOI":"10.1021\/ja2058567","volume":"133","author":"A Casitas","year":"2011","unstructured":"Casitas, A., Canta, M., Sol\u00e0, M., Costas, M. & Ribas, X. Nucleophilic aryl fluorination and aryl halide exchange mediated by a CuI\/CuIII catalytic cycle. J. Am. Chem. Soc. 133, 19386\u201319392 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"1911_CR58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ardp.200500168","volume":"339","author":"Z Ates-Alag\u00f6z","year":"2006","unstructured":"Ates-Alag\u00f6z, Z. et al. Synthesis and potent antimicrobial activities of some novel retinoidal monocationic benzimidazoles. Arch. Pharm. (Weinheim) 339, 74\u201380 (2006).","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"1911_CR59","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"1911_CR60","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1021\/acs.jpcb.7b00325","volume":"121","author":"S Xhani","year":"2017","unstructured":"Xhani, S., Esaki, S., Huang, K., Erlitzki, N. & Poon, G. M. K. Distinct roles for interfacial hydration in site-specific DNA recognition by ETS-family transcription factors. J. Phys. Chem. B 121, 2748 (2017).","journal-title":"J. Phys. Chem. B"},{"key":"1911_CR61","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"1911_CR62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.aal2066","volume":"356","author":"DS Tyler","year":"2017","unstructured":"Tyler, D. S. et al. Click chemistry enables preclinical evaluation of targeted epigenetic therapies. Science 356, 1397\u20131401 (2017).","journal-title":"Science"},{"key":"1911_CR63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC\u2013seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"1911_CR64","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V79.4.865.bloodjournal794865","volume":"79","author":"H Pahl","year":"1992","unstructured":"Pahl, H., Rosmarin, A. & Tenen, D. Characterization of the myeloid-specific CD11b promoter. Blood 79, 865\u2013870 (1992).","journal-title":"Blood"},{"key":"1911_CR65","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"1911_CR66","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.molcel.2022.10.025","volume":"82","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. Mol. Cell 82, 4428\u20134442.e7 (2022).","journal-title":"Mol. Cell"},{"key":"1911_CR67","volume":"19","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19, 633 (2018).","journal-title":"BMC Genomics"},{"key":"1911_CR68","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.celrep.2016.07.032","volume":"16","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. High-resolution mapping of RNA polymerases identifies mechanisms of sensitivity and resistance to BET inhibitors in t(8;21) AML. Cell Rep. 16, 2003\u20132016 (2016).","journal-title":"Cell Rep."},{"key":"1911_CR69","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41592-021-01187-3","volume":"18","author":"EA Hershberg","year":"2021","unstructured":"Hershberg, E. A. et al. PaintSHOP enables the interactive design of transcriptome- and genome-scale oligonucleotide FISH experiments. Nat. Methods 18, 937 (2021).","journal-title":"Nat. Methods"},{"key":"1911_CR70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41586-020-2432-4","volume":"583","author":"JC Wheat","year":"2020","unstructured":"Wheat, J. C. et al. Single-molecule imaging of transcription dynamics in somatic stem cells. Nature 583, 431\u2013436 (2020).","journal-title":"Nature"},{"key":"1911_CR71","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1261\/rna.079073.121","volume":"28","author":"A Imbert","year":"2022","unstructured":"Imbert, A. et al. FISH-quant v2: a scalable and modular tool for smFISH image analysis. RNA 28, 786\u2013795 (2022).","journal-title":"RNA"},{"key":"1911_CR72","unstructured":"Stark, R. & Brown, G. DiffBind: differential binding analysis of ChIP-Seq peak data. Bioconductor https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/DiffBind.html (2021)."},{"key":"1911_CR73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1911_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2014-15-1-r1","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"1911_CR75","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"1911_CR76","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1911_CR77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"1911_CR78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"1911_CR79","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1911_CR80","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"1911_CR81","unstructured":"Stauber, J. steidl-lab\/rePU.1sitioning: rerePU.1sitioning. Zenodo https:\/\/zenodo.org\/records\/13313910 (2024)."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01911-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:19:04Z","timestamp":1730301544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1038\/s41588-024-01911-7","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.S. has received research funding from GlaxoSmithKline, Bayer Healthcare, Aileron Therapeutics and Novartis; has received compensation for consultancy services and for serving on scientific advisory boards from GlaxoSmithKline, Bayer Healthcare, Celgene, Aileron Therapeutics, Stelexis Therapeutics and Pieris Pharmaceuticals; and has equity ownership in and is serving on the board of directors of Stelexis Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}